Blend Labs(BLND)

Search documents
Blend Labs(BLND) - 2022 Q2 - Quarterly Report
2022-08-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State or other jurisdiction of inc ...
Blend Labs(BLND) - 2022 Q1 - Earnings Call Transcript
2022-05-13 03:08
Blend Labs, Inc. (NYSE:BLND) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Crystal Sumner - Head, Legal Compliance and Risk Nima Ghamsari - Co-Founder and Head Tim Mayopoulos - President Marc Greenberg - Head, Finance Conference Call Participants Ryan Tomasello - KBW Maddie Schrage - KeyBanc Capital Markets Joseph Meares - Truist Matt Stotler - William Blair Arvind Ramnani - Piper Sandler Joe Vafi - Canaccord Crystal Sumner Good afternoon, and welcome to the Blends' First Q ...
Blend Labs(BLND) - 2022 Q1 - Earnings Call Presentation
2022-05-12 20:59
Blend Labs, Inc. Q1 2022 Earnings Supplemental Slides May 12, 2022 Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or Blend's future financial or operating performance. In some ca ...
Blend Labs(BLND) - 2022 Q1 - Quarterly Report
2022-05-12 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State or other jurisdiction of in ...
Blend Labs(BLND) - 2021 Q4 - Earnings Call Transcript
2022-04-01 03:17
Blend Labs, Inc. (NYSE:BLND) Q4 2021 Earnings Conference Call March 31, 2022 5:00 PM ET Company Participants Dan Smith - Head of Investor Relations Nima Ghamsari - Co-Founder, Chairman and Head Marc Greenberg - Head of Finance Timothy Mayopoulos - President Conference Call Participants Ryan Tomasello - Keefe, Bruyette, & Woods, Inc. Michael Turrin - Wells Fargo Securities, LLC Michael Ng - Goldman Sachs Group, Inc. Maddie Schrage - KeyBanc Capital Markets Joseph Vafi - Canaccord Genuity Corp. Joseph Meares ...
Blend Labs(BLND) - 2021 Q4 - Earnings Call Presentation
2022-03-31 22:21
Blend Labs, Inc. Q4 2021 Earnings Supplemental Slides Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or Blend's future financial or operating performance. In some cases, you can ...
Blend Labs(BLND) - 2021 Q4 - Annual Report
2022-03-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State or other jurisdiction of incorpo ...
Blend Labs(BLND) - 2021 Q3 - Quarterly Report
2021-11-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State or other jurisdiction o ...
Blend Labs(BLND) - 2021 Q3 - Earnings Call Presentation
2021-11-12 20:56
Blend Labs, Inc. Q3 2021 Earnings Supplemental Slides Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or Blend's future financial or operating performance. In some cases, you can ...
Blend Labs(BLND) - 2021 Q2 - Quarterly Report
2021-08-23 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State or other jurisdiction of inc ...